TScan Therapeutics
TCRX
TCRX
32 hedge funds and large institutions have $73.2M invested in TScan Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% more capital invested
Capital invested by funds: $69.9M → $73.2M (+$3.32M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
32
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.07M | |
| 2 | +$1.01M | |
| 3 | +$489K | |
| 4 |
Morgan Stanley
New York
|
+$386K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$146K |